Literature DB >> 15262886

Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment.

Nasreen Khalil1, Robert O'Connor.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal pulmonary fibrotic lung disease. The diagnostic histological changes are called usual interstitial pneumonia and are characterized by histological temporal heterogeneity, whereby normal lung tissue is interspersed with interstitial fibrosis, honeycomb cysts and fibroblast foci. Pulmonary functions show restricted volumes and capacities, preserved flows and evidence of decreased gas exchange. High-resolution computed axial tomography demonstrates evidence of fibrosis and lung remodelling such as honeycomb cysts and traction bronchiectasis. There is no known effective treatment for IPF, but lung transplantation improves survival.

Entities:  

Mesh:

Year:  2004        PMID: 15262886      PMCID: PMC450366          DOI: 10.1503/cmaj.1030055

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  90 in total

Review 1.  Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.

Authors:  G M Verleden; R M du Bois; D Bouros; M Drent; A Millar; J Müller-Quernheim; G Semenzato; S Johnson; G Sourvino; D Olivier; A Pietinalho; A Xaubet
Journal:  Eur Respir J Suppl       Date:  2001-09

2.  Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; M B Zimmerman; D A Schwartz; T E King; J Lynch; R Hegele; J Waldron; T Colby; N Müller; D Lynch; J Galvin; B Gross; J Hogg; G Toews; R Helmers; J A Cooper; R Baughman; C Strange; M Millard
Journal:  Am J Respir Crit Care Med       Date:  2001-07-15       Impact factor: 21.405

3.  Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung.

Authors:  M Kolb; P J Margetts; P J Sime; J Gauldie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

4.  Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression.

Authors:  C Ramos; M Montaño; J García-Alvarez; V Ruiz; B D Uhal; M Selman; A Pardo
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

5.  Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis.

Authors:  N Khalil; T V Parekh; R O'Connor; N Antman; W Kepron; T Yehaulaeshet; Y D Xu; L I Gold
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 6.  Pulmonary function tests in interstitial lung disease: what role do they have?

Authors:  E H Alhamad; J P Lynch; F J Martinez
Journal:  Clin Chest Med       Date:  2001-12       Impact factor: 2.878

Review 7.  Antifibrotic therapy for the treatment of pulmonary fibrosis.

Authors:  J A Lasky; L A Ortiz
Journal:  Am J Med Sci       Date:  2001-10       Impact factor: 2.378

8.  High short-term mortality following lung biopsy for usual interstitial pneumonia.

Authors:  J P Utz; J H Ryu; W W Douglas; T E Hartman; H D Tazelaar; J L Myers; M S Allen; D R Schroeder
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

Review 9.  Bronchoalveolar lavage in interstitial lung disease.

Authors:  U Costabel; J Guzman
Journal:  Curr Opin Pulm Med       Date:  2001-09       Impact factor: 3.155

10.  Autoantibodies in cryptogenic fibrosing alveolitis.

Authors:  S Singh; R du Bois
Journal:  Respir Res       Date:  2001-02-21
View more
  30 in total

1.  Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-kappaB pathway.

Authors:  Gabriele Gunella; Claudio Bardelli; Angela Amoruso; Ilario Viano; Piero Balbo; Sandra Brunelleschi
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Integration and Evaluation of Clinical Decision Support Systems for Diagnosis Idopathics Pulmonary Fibrosis (IPF).

Authors:  Yunhee Lee; Youngmoon Chae; Sungwan Jeon
Journal:  Healthc Inform Res       Date:  2010-12-31

3.  Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.

Authors:  Vivian Barry-Hamilton; Rhyannon Spangler; Derek Marshall; Scott McCauley; Hector M Rodriguez; Miho Oyasu; Amanda Mikels; Maria Vaysberg; Haben Ghermazien; Carol Wai; Carlos A Garcia; Arleene C Velayo; Brett Jorgensen; Donna Biermann; Daniel Tsai; Jennifer Green; Shelly Zaffryar-Eilot; Alison Holzer; Scott Ogg; Dung Thai; Gera Neufeld; Peter Van Vlasselaer; Victoria Smith
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

4.  Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis.

Authors:  Wataru Matsuyama; Masaki Watanabe; Yuko Shirahama; Hideo Mitsuyama; Ikkou Higashimoto; Mitsuhiro Osame; Kimiyoshi Arimura
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

5.  The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis.

Authors:  S Segawa; D Goto; A Iizuka; S Kaneko; M Yokosawa; Y Kondo; I Matsumoto; T Sumida
Journal:  Clin Exp Immunol       Date:  2016-08-02       Impact factor: 4.330

6.  Imaging of fibrogenesis in patients with idiopathic pulmonary fibrosis with cis-4-[(18)F]-Fluoro-L: -proline PET.

Authors:  Jules Lavalaye; Jan C Grutters; Ewoudt M W van de Garde; Monique M C van Buul; Jules M M van den Bosch; Albert D Windhorst; Fred J Verzijlbergen
Journal:  Mol Imaging Biol       Date:  2008-07-30       Impact factor: 3.488

Review 7.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

8.  Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.

Authors:  Jon T Giles; Sonye K Danoff; Jeremy Sokolove; Catriona A Wagner; Robert Winchester; Dimitrios A Pappas; Stanley Siegelman; Geoff Connors; William H Robinson; Joan M Bathon
Journal:  Ann Rheum Dis       Date:  2013-05-28       Impact factor: 19.103

Review 9.  Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.

Authors:  Bethany B Moore; Thomas A Moore
Journal:  Ann Am Thorac Soc       Date:  2015-11

10.  Laser capture microdissection reveals dose-response of gene expression in situ consequent to asbestos exposure.

Authors:  Qi Yin; Arnold R Brody; Deborah E Sullivan
Journal:  Int J Exp Pathol       Date:  2007-12       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.